Patents by Inventor Geun-Hyeog Lee

Geun-Hyeog Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10485786
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.
    Type: Grant
    Filed: March 30, 2018
    Date of Patent: November 26, 2019
    Assignee: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Kyu-Yang Yi, Sung-Eun Yoo, Nack-Jeong Kim, Jee-Hee Suh, Choun-Ki Joo, Jun-Sub Choi, Jae-Sik Yang, Geun-Hyeog Lee, Yun-Seok Cho, Jin-Ha Park, Hye-Sung Lee
  • Publication number: 20180221343
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.
    Type: Application
    Filed: March 30, 2018
    Publication date: August 9, 2018
    Applicants: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY, CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Kyu-Yang YI, Sung-Eun YOO, Nack-Jeong KIM, Jee-Hee SUH, Choun-Ki JOO, Jun-Sub CHOI, Jae-Sik YANG, Geun-Hyeog LEE, Yun-Seok CHO, Jin-Ha PARK, Hye-Sung LEE
  • Patent number: 9301954
    Abstract: The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: April 5, 2016
    Assignees: HANLIM PHARMACEUTICAL CO., LTD, CATHOLIC UNIVERSITY ACADEMIC COOPERATION FOUNDATION
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Young-Ok Jung, Geun-Hyeog Lee, Byong-Sun Choi, Jin-Ha Park, Eun-Young Kwak
  • Patent number: 8859531
    Abstract: The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: October 14, 2014
    Assignee: Hanlim Pharmaceutical Co., Ltd
    Inventors: Sang-Yong Lee, Geun-Hyeog Lee, Byong-Sun Choi, Jong-Hyeon Ryu, Jin-Ha Park, Mi-Jin O
  • Patent number: 8691842
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: April 8, 2014
    Assignees: Catholic University Industry Academic Cooperation Foundation, Hanlim Pharmaceutical Co., Ltd.
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Joo-Yeon Jhun, Geun-Hyeog Lee, Se-Wan Park, Jin-Ha Park, Eun-Young Kwak
  • Publication number: 20140018402
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating macular degeneration, which comprises benzopyran derivatives substituted with secondary amines including imidazole or pharmaceutically acceptable salts thereof as an active ingredient. The pharmaceutical composition of the present invention may be used in the form of eye drops.
    Type: Application
    Filed: March 29, 2011
    Publication date: January 16, 2014
    Applicants: CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION, KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Kyu-Yang Yi, Sung-Eun Yoo, Nack-Jeong Kim, Jee-Hee Suh, Choun-Ki Joo, Jun-Sub Choi, Jae-Sik Yang, Geun-Hyeog Lee, Yun-Seok Cho, Jin-Ha Park, Hye-Sung Lee
  • Publication number: 20130252929
    Abstract: The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.
    Type: Application
    Filed: November 18, 2011
    Publication date: September 26, 2013
    Applicant: HANLIM PHARMACEUTICAL CO., LTD.
    Inventors: Sang-Yong Lee, Geun-Hyeog Lee, Byong-Sun Choi, Jong-Hyeon Ryu, Jin-Ha Park, Mi-Jin O.
  • Publication number: 20130065920
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating osteoarthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Application
    Filed: March 4, 2011
    Publication date: March 14, 2013
    Applicant: HANLIM PHARMACETICAL CO., LTD.
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Young-Ok Jung, Geun-Hyeog Lee, Byong-Sun Choi, Jin-Ha Park, Eun-Young Kwak
  • Publication number: 20120172394
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Application
    Filed: October 8, 2009
    Publication date: July 5, 2012
    Applicants: HANLIM PHARMACEUTICAL CO., LTD., CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Joo-Yeon Jhun, Geun-Hyeog Lee, Se-Wan Park, Jin-Ha Park, Eun-Young Kwak
  • Publication number: 20100173028
    Abstract: The present invention provides an improved process for preparing a Vitis vinifera pip extract. And also, the present invention provides a pharmaceutical composition for preventing or treating rheumatoid arthritis including the Vitis vinifera pip extract as an active ingredient.
    Type: Application
    Filed: September 4, 2008
    Publication date: July 8, 2010
    Inventors: Jun-Ki Min, Mi-La Cho, Mi-Kyung Park, Yu-Jung Heo, Jin-Sil Park, Ho-Youn Kim, Jong-Hyeon Ryu, Hyun-Gyu Kim, Geun-Hyeog Lee